Literature DB >> 21530110

Clostridium difficile infection in humans and animals, differences and similarities.

E C Keessen1, W Gaastra, L J A Lipman.   

Abstract

Clostridium difficile is well known as the most common cause of nosocomial infections in human patients. In recent years a change in epidemiology towards an increase in incidence and severity of disease, not only inside the hospital, but also in the community, is reported. C. difficile is increasingly recognized in veterinary medicine as well and is now considered the most important cause of neonatal diarrhea in swine in North America. Research on the presence of C. difficile in production and companion animals revealed a huge overlap with strains implicated in human C. difficile infection (CDI). This has lead to the concern that interspecies transmission of this bacterium occurs. In this review C. difficile infections in humans and animals are compared. The pathogenesis, clinical signs, diagnosis and prevalence of CDI are described and similarities and differences of CDI between humans and animals are discussed.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21530110     DOI: 10.1016/j.vetmic.2011.03.020

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  28 in total

Review 1.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

2.  Carriage of Clostridium difficile by wild urban Norway rats (Rattus norvegicus) and black rats (Rattus rattus).

Authors:  Chelsea G Himsworth; David M Patrick; Sunny Mak; Claire M Jardine; Patrick Tang; J Scott Weese
Journal:  Appl Environ Microbiol       Date:  2013-12-06       Impact factor: 4.792

Review 3.  Diversity and Evolution in the Genome of Clostridium difficile.

Authors:  Daniel R Knight; Briony Elliott; Barbara J Chang; Timothy T Perkins; Thomas V Riley
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Cross-sectional study reveals high prevalence of Clostridium difficile non-PCR ribotype 078 strains in Australian veal calves at slaughter.

Authors:  Daniel R Knight; Sara Thean; Papanin Putsathit; Stan Fenwick; Thomas V Riley
Journal:  Appl Environ Microbiol       Date:  2013-02-08       Impact factor: 4.792

5.  Effects of spray-dried porcine plasma on fecal microbiota in nursery pigs.

Authors:  Huyen Tran; Christopher L Anderson; Justin W Bundy; Samodha C Fernando; Phillip S Miller; Thomas E Burkey
Journal:  J Anim Sci       Date:  2018-04-03       Impact factor: 3.159

6.  Genus-Wide Assessment of Antibiotic Resistance in Lactobacillus spp.

Authors:  Ilenia Campedelli; Harsh Mathur; Elisa Salvetti; Siobhán Clarke; Mary C Rea; Sandra Torriani; R Paul Ross; Colin Hill; Paul W O'Toole
Journal:  Appl Environ Microbiol       Date:  2018-12-13       Impact factor: 4.792

7.  Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011.

Authors:  C W Knetsch; T R Connor; A Mutreja; S M van Dorp; I M Sanders; H P Browne; D Harris; L Lipman; E C Keessen; J Corver; E J Kuijper; T D Lawley
Journal:  Euro Surveill       Date:  2014-11-13

8.  The duration of antibiotic treatment is associated with carriage of toxigenic and non-toxigenic strains of Clostridioides difficile in dogs.

Authors:  Carolina Albuquerque; Davide Pagnossin; Kirsten Landsgaard; Jessica Simpson; Derek Brown; June Irvine; Denise Candlish; Alison E Ridyard; Gillian Douce; Caroline Millins
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

9.  Molecular Detection of Toxigenic Clostridioides difficile among Diarrheic Dogs and Cats: A Mounting Public Health Concern.

Authors:  Ahmed Samir; Khaled A Abdel-Moein; Hala M Zaher
Journal:  Vet Sci       Date:  2021-05-22

10.  Novel molecular type of Clostridium difficile in neonatal pigs, Western Australia.

Authors:  Michele M Squire; Glen P Carter; Kate E Mackin; Anjana Chakravorty; Torbjörn Norén; Briony Elliott; Dena Lyras; Thomas V Riley
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.